BNP Paribas Financial Markets’s Titan Medical Inc. Ordinary Shares TMDI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-700
Closed -$462 4127
2022
Q4
$462 Buy
+700
New +$369 ﹤0.01% 3865
2022
Q3
Sell
-800
Closed -$406 5094
2022
Q2
$406 Sell
800
-2,353
-75% -$1.15K ﹤0.01% 3962
2022
Q1
$1.66K Buy
+3,153
New +$1.83K ﹤0.01% 3924

Other funds holding TMDI

BNP Paribas Financial Markets's TMDI Position: Q1 2023 in Review

BNP Paribas Financial Markets sold out of Titan Medical Inc. Ordinary Shares (TMDI) in Q1 2023, closing a stake of 700 shares — an estimated $462 sold.

BNP Paribas Financial Markets first reported a position in TMDI in Q1 2022 and held it in 3 quarters. The position peaked at $1.66K in Q1 2022. 12 funds tracked by Wall St. Rank hold TMDI as of Q1 2023.

  • BNP Paribas Financial Markets reported no remaining Titan Medical Inc. Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 700 Titan Medical Inc. Ordinary Shares shares in Q1 2023, an estimated $462.
  • BNP Paribas Financial Markets first reported a position in Titan Medical Inc. Ordinary Shares in Q1 2022 and held it in 3 quarters.
  • BNP Paribas Financial Markets's Titan Medical Inc. Ordinary Shares position peaked at $1.66K in Q1 2022.
  • 12 funds tracked by Wall St. Rank held Titan Medical Inc. Ordinary Shares as of Q1 2023.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2023, filed 12 May 2023.